Working together for more than a decade, the team of Kraws and Goldfarb has been recognized by consistently winning several of the industry's most sought-after and prestigious awards.
Frequently ranked as one of the "Top 20 Pharmaceutical Analysts on Wall Street" -Institutional Investor
5-Star Rating in 2001 - Zacks
One of the top biotechnology analysts on Wall Street - Zacks
One of the top 10 pharmaceutical analysts for stock selection performance - Starmine.com
Number one among all pharmaceutical analysts for stock performance in 2001 - Starmine.com